HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.

Abstract
Genetic studies have added to the understanding of complex diseases. Here, we used a combined genetic approach for risk-loci identification in a prototypic, organ-specific, autoimmune disease, namely experimental epidermolysis bullosa acquisita (EBA), in which autoantibodies to type VII collagen (COL7) and neutrophil activation cause mucocutaneous blisters. Anti-COL7 IgG induced moderate blistering in most inbred mouse strains, while some showed severe disease or were completely protected. Using publicly available genotyping data, we identified haplotype blocks that control blistering and confirmed two haplotype blocks in outbred mice. To identify the blistering-associated genes, haplotype blocks encoding genes that are differentially expressed in EBA-affected skin were considered. This procedure identified nine genes, including retinoid-related orphan receptor alpha (RORα), known to be involved in neurological development and function. After anti-COL7 IgG injection, RORα+/- mice showed reduced blistering and homozygous mice were completely resistant to EBA induction. Furthermore, pharmacological RORα inhibition dose-dependently blocked reactive oxygen species (ROS) release from activated neutrophils but did not affect migration or phagocytosis. Thus, forward genomics combined with multiple validation steps identifies RORα to be essential to drive inflammation in experimental EBA.
AuthorsHengameh Sadeghi, Yask Gupta, Steffen Möller, Unni K Samavedam, Martina Behnen, Anika Kasprick, Katja Bieber, Susen Müller, Kathrin Kalies, Andreia de Castro Marques, Andreas Recke, Enno Schmidt, Detlef Zillikens, Tamás Laskay, Jean Mariani, Saleh M Ibrahim, Ralf J Ludwig
JournalThe Journal of pathology (J Pathol) Vol. 237 Issue 1 Pg. 111-22 (Sep 2015) ISSN: 1096-9896 [Electronic] England
PMID25953430 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Chemical References
  • Autoantibodies
  • Collagen Type VII
  • Immunoglobulin G
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • RORA protein, human
  • Reactive Oxygen Species
  • Rora protein, mouse
  • SR 3335
  • Sulfonamides
  • Thiophenes
Topics
  • Animals
  • Autoantibodies (immunology)
  • Collagen Type VII (immunology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Partial Agonism
  • Epidermolysis Bullosa Acquisita (genetics, immunology, metabolism, pathology)
  • Genetic Predisposition to Disease
  • Genomics (methods)
  • Haplotypes
  • Heterozygote
  • Homozygote
  • Immunoglobulin G (immunology)
  • Mice, Knockout
  • Neutrophil Activation
  • Neutrophils (immunology, metabolism)
  • Nuclear Receptor Subfamily 1, Group F, Member 1 (antagonists & inhibitors, deficiency, genetics, immunology, metabolism)
  • Phenotype
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • Skin (drug effects, immunology, metabolism, pathology)
  • Species Specificity
  • Sulfonamides (pharmacology)
  • Thiophenes (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: